XBIT · XBiotech

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

5217 Winnebago Lane, 8201 E Riverside Dr Ste 100, Austin, TX, 78744, United States
Biotechnology
Healthcare

Market Cap

56.4M

52 Wk Range

$1.80 - $2.73

Previous Close

$1.85

Open

$1.86

Volume

62,580

Day Range

$1.78 - $1.87

Enterprise Value

-106M

Cash

105M

Avg Qtr Burn

-4.521M

Insider Ownership

38.08%

Institutional Own.

6.72%

Qtr Updated

Sep 30th 2026